Form 4 for STE Steris
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-04 · accession 0001628280-25-030033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-06 | 2025-06-04 | STE | Madsen Julia | SVP, GM, Life Sciences | F - Tax | $242.10 | -194 | 10.8K | -2% | -$47.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-04 | F | D | 194 | $242.10 | 10,762 | D | — | — | (F1) 194 shares were withheld from the 542 restricted shares that vested on June 4, 2025. These 194 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 542 ordinary shares were awarded to Ms. Madsen on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. (F2) As of June 4, 2025, 4,147 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |